Response to therapy in a patient with coexisting Langerhans cell histiocytosis (LCH) and neuroblastoma emphasizes the need for the addition of LCH-directed therapy

被引：0
|
作者：
Grant, RM [1 ]
Capra, M [1 ]
Gerstle, T [1 ]
Weitzman, S [1 ]
机构：
[1] Hosp Sick Children, Toronto, ON M5G 1X8, Canada
来源：
PEDIATRIC BLOOD & CANCER | 2004年 / 43卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：204 / 204
页数：1
相关论文
共 37 条
  • [1] Focal Langerhans Cell Histiocytosis (LCH) Coexisting With Renal Cell Carcinoma
    Pimentel, Agustin
    Haupt, Riccardo
    Sihelnik, Stephen A.
    Kimmel, William B.
    Swierczynski, Sharon L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (05) : E107 - E109
  • [2] Retrospective Analysis of Clofarabine Salvage Therapy in Refractory Multifocal Langerhans Cell Histiocytosis (LCH)
    Parekh, Deevyashali
    Lin, Howard
    McClain, Kenneth L.
    Gulati, Nitya
    Eckstein, Olive S.
    El-Mallawany, Nader Kim
    Agrusa, Jennifer Elise
    Allen, Carl E.
    BLOOD, 2023, 142
  • [3] Langerhans Cell Histiocytosis (LCH) in the Modern Era: Excellent Local Control With Radiation Therapy (RT)
    Lok, B. H.
    Chelius, M. R.
    Yahalom, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E494 - E494
  • [4] Spontaneous gonadotrophin deficiency recovery in an adult patient with langerhans cell histiocytosis (LCH)
    Makras P.
    Papadogias D.
    Kontogeorgos G.
    Piaditis G.
    Kaltsas G.A.
    Pituitary, 2005, 8 (2) : 169 - 174
  • [5] Evans syndrome in a patient with Langerhans cell histiocytosis: possible pathogenesis of autoimmunity in LCH
    Yoichiro Tsuji
    Kazuhiro Kogawa
    Kohsuke Imai
    Hirokazu Kanegane
    Junichiro Fujimoto
    Shigeaki Nonoyama
    International Journal of Hematology, 2008, 87 : 75 - 77
  • [6] Evans syndrome in a patient with Langerhans cell histiocytosis: possible pathogenesis of autoimmunity in LCH
    Tsuji, Yoichiro
    Kogawa, Kazuhiro
    Imai, Kohsuke
    Kanegane, Hirokazu
    Fujimoto, Junichiro
    Nonoyama, Shigeaki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2008, 87 (01) : 75 - 77
  • [7] Intravenous Immunoglobulin (IVIG) Therapy for Patients with Langerhans Cell Histiocytosis (LCH)-Related Neurodegenerative Diseases of the CNS
    Imashuku, Shinsaku
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2015, 14 (06) : 688 - 690
  • [8] 2′-Chlorodeoxyadenosine (2-CdA) as Salvage Therapy for Langerhans Cell Histiocytosis (LCH). Results of the LCH-S-98 Protocol of the Histiocyte Society
    Weitzman, Sheila
    Braier, Jorge
    Donadieu, Jean
    Egeler, R. Maarten
    Grois, Nicole
    Ladisch, Stephan
    Poetschger, Ulrike
    Webb, David
    Whitlock, James
    Arceci, Robert J.
    PEDIATRIC BLOOD & CANCER, 2009, 53 (07) : 1271 - 1276
  • [9] Langerhans Cell Histiocytosis (LCH) of the Tonsil in Adult Patient: An Uncommon Disease at an Uncommon Site
    Khera, Rachna
    Ahmed, Faiq
    Murthy, Sudha
    Mallavarapu, Krishna Mohan
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2017, 33 (02) : 276 - 277
  • [10] Prosthodontic Treatment of a Class IV ACP PDI Patient, with Langerhans Cell Histiocytosis (LCH)
    Papavasiliou, George
    Kamposiora, Phophi
    Sklavounou, Alexandra
    Christopoulos, Panos
    JOURNAL OF PROSTHODONTICS-IMPLANT ESTHETIC AND RECONSTRUCTIVE DENTISTRY, 2011, 20 : S14 - S19
1234